Correlates of IL-10 and IL-12 concentrations in cervical secretions.

作者: Patti E Gravitt , Allan Hildesheim , Rolando Herrero , Mark Schiffman , Mark E Sherman

DOI: 10.1023/A:1023305827971

关键词:

摘要: Interindividual variations in host immune responses to HPV infection are thought be important determinants of viral persistence and progression cervical intraepithelial neoplasia cancer. However, few studies have measured local markers at the site (e.g., mucosa). We sought determine biologic correlates IL-10 IL-12 concentrations secretions. Cervical secretions were passively collected using a WeckCel sponge from 247 women participating natural history study human papillomavirus as part an immunologic ancillary study. determined standard ELISA assays.In general, levels significantly intercorrelated (Pearson's correlation coefficient = 0.6) but had somewhat different determinants. Significant increases (P < 0.05) observed for nonovulatory phases menstrual cycle, postmenopausal status, recent use oral contraceptives (OC), low secretion volume, macrolevels heme contamination, high vaginal pH. Increasing also among smokers, with increasing numbers lifetime sex partners, who report having less frequent (less than once per week), however, these results not statistically significant. Significantly higher OC users, There was non-statistically significant observation nonsmokers, pregnancies, contamination. failed observe association between or this cross-sectional sample. Future analyses cytokine should control inherent variation due hormonal influences, hemoglobin pH, volume differences.

参考文章(23)
I. H. Frazer, R. Tindle, Cell mediated immunity to papillomaviruses Leeds University Press. pp. 151- 164 ,(1999)
Philip E. Castle, Allan Hildesheim, Fredrick P. Bowman, Howard D. Strickler, Joan L. Walker, Terri Pustilnik, Robert P. Edwards, Peggy A. Crowley-Nowick, Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. Journal of Clinical Immunology. ,vol. 22, pp. 23- 27 ,(2002) , 10.1023/A:1014252402630
J Cuzick, G Terry, L Ho, J Monaghan, A Lopes, P Clarkson, I Duncan, Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women British Journal of Cancer. ,vol. 82, pp. 1348- 1352 ,(2000) , 10.1054/BJOC.1999.1103
Paulo C Maciag, Nicolas F Schlecht, Patricia SA Souza, Eduardo L Franco, Luisa L Villa, M Luiza Petzl-Erler, None, Major Histocompatibility Complex Class II Polymorphisms and Risk of Cervical Cancer and Human Papillomavirus Infection in Brazilian Women Cancer Epidemiology, Biomarkers & Prevention. ,vol. 9, pp. 1183- 1191 ,(2000)
Raymond J. Apple, Henry A. Erlich, William Klitz, M. Michele Manos, Thomas M. Becker, Cosette M. Wheeler, HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genetics. ,vol. 6, pp. 157- 162 ,(1994) , 10.1038/NG0294-157
Mark H. Stoler, HPV testing is not useful for LSIL Triage--but stay tuned. Advances in Anatomic Pathology. ,vol. 8, pp. 160- 164 ,(2001) , 10.1097/00125480-200105000-00004
J. A. Suzich, S. J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, R. Schlegel, Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 11553- 11557 ,(1995) , 10.1073/PNAS.92.25.11553
S. Joyce, Natural T cells: Cranking up the immune system by prompt cytokine secretion Proceedings of the National Academy of Sciences of the United States of America. ,vol. 97, pp. 6933- 6935 ,(2000) , 10.1073/PNAS.97.13.6933